✦ LIBER ✦

In vitro evaluation of sun protection factors of sunscreen agents using a novel UV spectrophotometric technique

✍ Scribed by M. D. Bleasel; S. Aldous

Book ID: 111086263
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 157 KB
Volume: 30
Category: Article
ISSN: 0142-5463
DOI: 10.1111/j.1468-2494.2008.00453.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of Application Amount on Sunsc

Influence of Application Amount on Sunscreen Photodegradation in in vitro Sun Protection Factor Evaluation: Proposal of A Skin-Mimicking Substrate

✍ Yoshimasa Miura; Tetsuji Hirao; Masato Hatao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 610 KB

In vitro determination of the sun protec

In vitro determination of the sun protection factor of sunscreens through photoacoustic spectroscopy: A new approach

✍ S. L. Oliveira; A. M. Mansanares; E. C. da Silva; P. R. Barja 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 82 KB

Comparison of sun protection factors det

Comparison of sun protection factors determined by an in vivo and different in vitro methodologies: a study with 58 different commercially available sunscreen products

✍ U. Heinrich; H. Tronnier; D. Kockott; R. Kuckuk; H. M. Heise 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Evaluation of sun protection factor of c

Evaluation of sun protection factor of cosmetic formulations by a simple visual in vitro method mimicking the in vivo method

✍ Leonardo R. de Paula; André L. A. Parussulo; Koiti Araki; Henrique E. Toma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

In vitro and in vivo evaluation of WK-X-

In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques

✍ Veronika Jekerle; Werner Klinkhammer; Deborah A. Scollard; Kerstin Breitbach; Ra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 776 KB

## Abstract Overexpression of the multidrug resistance proteins P‐glycoprotein (Pgp) and breast cancer resistance protein (BCRP) results in treatment failure of many malignancies including ovarian cancer. Dual inhibition of Pgp and BCRP may restore the sensitivity of resistant cells to anticancer d